FRISINA, Nicola
 Distribuzione geografica
Continente #
NA - Nord America 3.810
EU - Europa 3.151
AS - Asia 1.169
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
AF - Africa 2
Totale 8.145
Nazione #
US - Stati Uniti d'America 3.781
SE - Svezia 946
IE - Irlanda 915
CN - Cina 693
SG - Singapore 409
UA - Ucraina 390
DE - Germania 359
FI - Finlandia 182
GB - Regno Unito 134
IT - Italia 118
IN - India 42
BE - Belgio 27
CA - Canada 26
RU - Federazione Russa 21
CZ - Repubblica Ceca 17
FR - Francia 14
IR - Iran 14
CL - Cile 5
PL - Polonia 5
CH - Svizzera 4
NL - Olanda 4
AT - Austria 3
AU - Australia 3
BG - Bulgaria 3
EU - Europa 3
DK - Danimarca 2
HK - Hong Kong 2
LV - Lettonia 2
PK - Pakistan 2
AM - Armenia 1
BO - Bolivia 1
BR - Brasile 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ES - Italia 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
JP - Giappone 1
KR - Corea 1
LK - Sri Lanka 1
LU - Lussemburgo 1
NG - Nigeria 1
PA - Panama 1
RO - Romania 1
SA - Arabia Saudita 1
TR - Turchia 1
Totale 8.145
Città #
Dublin 915
Jacksonville 847
Chandler 778
Nyköping 456
Singapore 340
Beijing 273
Ashburn 189
Cambridge 150
Princeton 150
Medford 141
Des Moines 120
Ann Arbor 114
Boardman 108
Dearborn 86
Lancaster 61
New York 58
Bremen 52
Shenyang 48
Jinan 47
Wilmington 47
Woodbridge 45
Munich 44
Helsinki 33
Los Angeles 32
Zhengzhou 30
Hebei 28
Brussels 27
San Mateo 27
Nanjing 25
Tianjin 24
Pune 22
Taizhou 22
Turin 22
Haikou 21
Ningbo 19
Augusta 18
Hangzhou 17
Ottawa 17
Brno 16
Houston 14
Lanzhou 13
Taiyuan 13
Seattle 12
Falls Church 11
Jiaxing 11
Nanchang 11
Ardabil 10
Changsha 10
Guangzhou 10
Leawood 10
Fuzhou 9
Hyderabad 9
Monmouth Junction 9
Auburn Hills 7
Messina 7
Clearwater 6
Mumbai 6
Norwalk 6
Rome 6
Milan 5
Washington 5
Catania 4
Chaoyang 4
Saint Petersburg 4
Santa Clara 4
Toronto 4
Dalian 3
Florence 3
Jeffries 3
Montreal 3
Novokuznetsk 3
Paterno 3
Polverigi 3
Rho 3
Sofia 3
Vienna 3
Aci Castello 2
Cairo Montenotte 2
Central 2
Changle 2
Den Haag 2
Gropello Cairoli 2
Hanover 2
Harbin 2
Hefei 2
Islamabad 2
Kemerovo 2
London 2
Montreux 2
Phoenix 2
Quanzhou 2
Radomsko 2
Redmond 2
Rio Saliceto 2
Shanghai 2
Stockholm 2
Strasbourg 2
Viagrande 2
Vittoria 2
Warsaw 2
Totale 5.767
Nome #
Cell proliferation/cell death balance in renal cell cultures after exposure to a static magnetic field 92
Effects of a long-term treatment with raloxifene on insulin sensitivity in postmenopausal women 90
Bisphosphonates in the treatment of thalassemia-associated osteoporosis. 90
Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study 88
Recombinant human erythropoietin stimulates angiogenesis and healing of ischemic skin wounds 86
Effects of Homocysteine on Proliferation, Necrosis, and Apoptosis of Vascular Smooth Muscle Cells in Culture and Influence of Folic Acid 85
Long-term hemostatic effects of cholesterol-lowering therapy with atorvastatin 84
Onset of hypothyroidism with polymyositis-like clinical features in elderly patients 83
Bone remodeling and regulation of sRANKL/OPG balance after genistein administration in osteopenic, postmenopausal women 81
Behavior of vascular endothelial growth factor and erythropoietin throughout the menstrual cycle in healthy women. 80
Statins in the prevention of cardiovascular events in patients with renal failure. 78
EFFECTS OF THE PHYTOESTROGEN GENISTEIN ON CARDIOVASCULAR RISK FACTORS IN POSTMENOPAUSAL WOMEN. 75
AQP1 in red blood cells of uremic patients during hemodialytic treatment 74
Aquaporin-2 water channels in spontaneously hypertensive rats 74
SICUREZZA ED EFFICACIA DELLA GENISTEINA IN DONNE OSTEOPENICHE IN POSTMENOPAUSA 73
Recombinant erythropoietin and hypertension 73
Aldosterone and prolactin secretion. II. Plasma renin activity, blood potassium and cortisol levels following administration of sulpiride in normal subjects 72
Circadian rhythm of hydration in healthy subjects and uremic patients studied by bioelectrical impedance analysis 72
Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: A two-year randomized, double-blind, placebo-controlled study 71
ASSETTO EMATOLOGICO DI UN GRUPPO DI SOGGETTIAFFETTI DA MORBO DI COOLEY:STUDIO DEL COMPORTAMENTO DELL'ERITROPOIETINA PLASMATICA 71
Effect of two different models of hemodiafiltration potassium removal on QT dispersion 70
Bisphosphonates in the treatment of thalassemia-associated osteoporosis. 70
A trigonometric approximation method for the monostatic radar cross section 70
Correlation between quality of life assessment and a personality neurobiologic model in dialyzed patients 68
ELIZABETHAN STUDIES IN ITALY IN 1989 AND 1990 67
Administration of recombinant erythropoietin determines increase of peripheral resistances in patients with hypovolemic shock 67
Oxidative stress, sister chromatid exchanges and apoptosis in the pathogenesis of lymphocytopenia in ESRD patients 67
Effect of a calcium antagonist, nifedipine, on the cold pressor test in normal subjects 66
Association between primary hyperprathyroidism (p-hyperPTH) and nodular toxic goiter (NTG): a prospective study at an outpatient service for osteoporosis 66
Alterations in induced potassium calcium efflux in the erythrocytes of patients with autosomal dominant polycystic kidney disease and hypertension 66
Association of primary hyperparathyoidism (p-hyperPTH) with nodular toxic goiter (NTG): a prospective study at an outpatient osteoporosis service. 65
Are there potential non-lipid-lowering uses of statins in the kidney? 65
Cold pressor test raises serum concentrations of ICAM-1, VCAM- 1, and E-selectin in normotensive and hypertensive patients 64
Bisphosphonates in the treatment of thalassemia-induced osteoporosis 64
Bone mineral density, quantitative ultrasound parameters and bone metabolism in postmenopausal women with depression 64
Hashimoto's thyroiditis is a frequent association of primary hyperparathyroidism, of which it modifies biochemical and bone density indices 63
Effects of genistein on hot flushes in early postmenopausal women: a randomized, double-blind EPT- and Placebo-controlled Study 63
Effects of the phytoestrogen genistein on the circulating soluble receptor activator of nuclear factor kappa B ligand-osteoprotegerin system in early postmenopausal women 63
Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo controlled study. 63
Preventing bone loss during androgen deprivation therapy for prostate cancer: Early experience with neridronate. EUROPEAN UROLOGY, vol. 47; p. 575 - 581 63
Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women - A randomized trial 63
Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: A randomized double-blind placebo-controlled study 63
Flushing due to calcitonin and the opioid system 62
OPG and sRANKL serum concentrations in osteopenic, postmenopausal women after 2-year genistein administration. 62
Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study 62
Cardiovascular effects of raloxifene hydrochloride 62
Nonrobertsonian translocation t(6;11) is associated with infertility in an oligoazoospermic male 62
L'azione di un bolo di rHu-EPO sul flusso muscolare di soggetti uremici 62
Efficacy of genistein aglycone on some cardiovascular risk factors and homocysteine levels: A follow-up study 61
Effect of genistein on endothelial function in postmenopausal women: A randomized, double-blind, controlled study 61
Therapy with vasopressin receptor antagonists: the aquaretics 61
ATTIVITÀ RENINICA, ANGIOTENSINA II, ALDOSTERONE PLASMATICI IN SOGGETTI ANZIANI. 61
From the oxygen to the organ protection: erythropoietin as protagonist in internal medicine 60
Statins in nephrotic syndrome: a new weapon against tissue injury. 59
THE CIRCADIAN-RHYTHM OF ERYTHROPOIETIN IN SUBJECTS WITH PRE- TERMINAL UREMIA 59
Osteoporosis and beta-thalassemia major: Role of the IGF- I/IGFBP-III axis 59
Chromosomal damage and atherosclerosis. A protective effect from simvastatin. 58
Hypokalemic myopathy in pseudohyperaldosteronism induced by fluoroprednisolone-containing nasal spray. 57
Effect of long-term treatment with Raloxifene on mammary density in postmenopausal women. 57
Cardiovascular remodeling, apoptosis, and drugs 57
Recombinant erythropoietin and cardiovascular risk in uremia. 57
The behaviour of serum triiodothyronine in autonomous thyroid nodules and its relationship with the clinical feature 57
Genistein effects on quantitative ultrasound parameters and bone mineral density in osteopenic postmenopausal women 56
Hashimoto's thyroiditis (HT) is a frequent association of primary hyperparathyroidism (p-hyperPTH), of which it modifies biochemical and bone density indices 55
Reduced bcl-2 concentrations in hypertensive patients after lisinopril or nifedipine administration 55
Urinary excretion of aquaporin-2 water channel during pregnancy 55
Does captopril have a direct pro-apoptotic effect? 55
Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma NO concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women 54
Effect of a prostacyclin analogue, iloprost, on urinary aquaporin-2 excretion in humans 54
Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: a randomized, double-blind, placebo-controlled study 54
MARKERS OF ENDOTHELIAL AND PLATELET STATUS IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND PLYCYTHEMIA VERA 53
Effect of interleukin 8 and ICAM-1 on calcium-dependent outflow of K+ in erythrocytes from subjects with essential hypertension 53
Positive effects of the phytoestrogen genistein on bone metabolism in postmenopausal women 53
Urinary Neutrophil Gelatinase-Associated Lipocalin (NGAL) is associated with severity of renal disease in proteinuric patients 53
The effect of two different protocols of potassium haemodiafiltration on QT dispersion 53
Kidney aging: From phenotype to genetics 53
Three-year effectiveness of intravenous pamidronate versus pamidronate plus slow-release sodium fluoride for postmenopausal osteoporosis 53
Long-term transdermal estrogen therapy improves lipid profile but not insulin resistance in healthy postmenopausal women 52
Rapid and transient lymphocytopenia after i.v. administration of high doses of human recombinant erythropoietin 52
Effect of unsaturated fatty acids on basal plasma renin activity and afterpostural stimulation 52
DOES ERYTHROPOIETIN AUGMENT THE CA2+-MEDIATED K+ FLOW INTO THE RED-BLOOD-CELLS IN NORMOTENSIVE AND HYPERTENSIVE SUBJECTS 52
The "lively" cytokines network in beta-Thalassemia Major-related osteoporosis. 52
Renal failure from mitochondrial cytopathies 51
Osteoprotegerin, IL-6, IL-1, TNF-alpha and TGF-beta concentrations during acetate-free biofiltration 51
DIFFERENT ANSWER TO RECOMBINANT-HUMAN-ERYTHROPOIETIN IN ANEPHRIC AND NONANEPHRIC HEMODIALYZED PATIENTS 51
Rapid, progressive deterioration of renal function following erroneousADMINISTRATION OF HIGH DOSES OF SUBCUTANEOUS RECOMBINANT ERYTHROPOIETIN] 51
Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo-controlled study 51
Hemostasis and fibrinolysis factors in first-degree relatives of patients with type 2 diabetes without hypertension 51
Effects of hormonal replacement therapy on bone metabolism in young adults with beta-thalassemia major 51
Increased indexes of thrombin activation in advanced stages of hypertension 51
Metabolic effects of dehydroepiandrosterone replacement therapy in postmenopausal women 51
Effects of lisinopril administration on blood bcl-2 concentrations in patients with immunoglobulin A nephropathy 51
Effetti di un fitoestrogeno (Genisteina) su marcatori citogenetici in donne in post menopausa. 51
Erythropoietin and the brain: from neurodevelopment to neuroprotection 50
INFLUENCE OF THE TREATMENT WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN ON PLASMA-CONCENTRATION OF INTERLEUKIN-1-ALPHA AND TUMOR-NECROSIS-FACTOR-ALPHA IN HEMODIALYZED SUBJECTS 50
Gastro-intestinal permeability is increased in patients with limited systemic sclerosis 50
Loss of circadian rhythm in erythropoietin production in a patient with renal erythropoietin secreting neoplasia 50
Effetti dell'alendronato sul Sister Chromatid Exchanges (SCE) in pazienti con osteoporosi post-menopausale (dati preliminari). 50
Treatment of the nephritic syndrome in elderly with human intravenousimmunoglobulins. 50
Positive effects of the isoflavone genistein on cardiovascular system in osteopenic, postmenopausal women 49
Totale 6.207
Categoria #
all - tutte 34.822
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.822


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020760 0 0 0 0 0 0 182 146 11 222 195 4
2020/2021936 141 8 244 41 19 135 4 109 0 69 124 42
2021/20221.213 5 263 13 26 62 10 59 39 56 225 133 322
2022/20232.829 203 272 128 221 251 279 25 193 1.107 34 85 31
2023/2024619 48 99 41 58 35 154 26 34 4 35 9 76
2024/2025575 60 25 46 189 114 132 9 0 0 0 0 0
Totale 8.206